Showing 4341-4360 of 8668 for: Cochrane Systematic Reviews Back
- Intravenous immunoglobulin for the treatment of childhood encephalitis
Cochrane Systematic Reviews, 28-Sep-2017
Encephalitis is a syndrome of neurological dysfunction due to inflammation of the brain parenchyma, caused by an infection or an exaggerated host immune response, or both. Attenuation of brain inflammation through modulation of the immune response could i
- Intravenous immunoglobulin for the treatment of Kawasaki disease in children
Cochrane Systematic Reviews, 20-Oct-2003
Kawasaki disease is the most common cause of acquired heart disease in children in developed countries. The coronary arteries supplying the heart can be damaged in Kawasaki disease. The principal advantage of timely diagnosis is the potential to prevent t
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Cochrane Systematic Reviews, 16-Sep-2013
Mortality from sepsis and septic shock remains high. Results of trials on intravenous immunoglobulins (IVIG) as adjunctive therapy for sepsis have been conflicting. This is an update of a Cochrane review that was originally published in 1999 and updated i
- Intravenous immunoglobulins for epilepsy
Cochrane Systematic Reviews, 2-Dec-2019
Epilepsy is a common neurological condition, with an estimated incidence of 50 per 100,000 persons. People with epilepsy may present with various types of immunological abnormalities, such as low serum immunoglobulin A (IgA) levels, lack of the immunoglob
- Intravenous immunoglobulins for multiple sclerosis
Cochrane Systematic Reviews, 21-Jul-2003
Animal experiments suggest that intravenous immunoglobulins can reverse some of the disease process of central nervous system demyelination. Subsequently, clinical trials of intravenous immunoglobulins have been conducted in people with multiple sclerosis
- Intravenous in‐line filters for preventing morbidity and mortality in neonates
Cochrane Systematic Reviews, 6-Aug-2015
Venous access is an essential part of caring for the sick neonate. However, problems such as contamination of fluids with bacteria, endotoxins and particulates have been associated with intravenous infusion therapy. Intravenous in-line filters claim to be
- Intravenous iron therapy for non‐anaemic, iron‐deficient adults
Cochrane Systematic Reviews, 20-Dec-2019
Iron deficiency is one of the most common nutritional deficiencies, and has a number of physiological manifestations. Early, or non-anaemic iron deficiency can result in fatigue and diminished exercise capacity. Oral iron preparations have a high incidenc
- Intravenous lidocaine for the treatment of background or procedural burn pain
Cochrane Systematic Reviews, 16-Oct-2014
This is an update of the review on "Lidocaine for pain relief in burn injured patients" first published in Issue 3, 2007, and first updated in 2012. Pain is a major issue for people with many different types of wounds, in particular those people with burn
- Intravenous magnesium for acute myocardial infarction
Cochrane Systematic Reviews, 18-Apr-2007
Mortality and morbidity from acute myocardial infarction (AMI) remain high. Intravenous magnesium started early after the onset of AMI is thought to be a promising adjuvant treatment. Conflicting results from earlier trials and meta-analyses warrant a sys
- Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department
Cochrane Systematic Reviews, 21-May-2014
Asthma is a chronic respiratory condition characterised by airways inflammation, constriction of airway smooth muscle and structural alteration of the airways that is at least partially reversible. Exacerbations of asthma can be life threatening and place
- Intravenous magnesium sulfate for treating children with acute asthma in the emergency department
Cochrane Systematic Reviews, 29-Apr-2016
Acute asthma in children can be life-threatening and must be treated promptly in the emergency setting. Intravenous magnesium sulfate is recommended by various guidelines for cases of acute asthma that have not responded to first-line treatment with bronc
- Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit
Cochrane Systematic Reviews, 31-Jan-2017
Proper sedation for neonates undergoing uncomfortable procedures may reduce stress and avoid complications. Midazolam is a short-acting benzodiazepine that is used increasingly in neonatal intensive care units (NICUs). However, its effectiveness as a seda
- Intravenous naftidrofuryl for critical limb ischaemia
Cochrane Systematic Reviews, 11-Jul-2012
Peripheral arterial disease affects five per cent of men and women by late middle age. Approximately 25% of those affected will develop critical limb ischaemia (rest pain, ulceration and gangrene) within five years. Naftidrofuryl is a vasoactive drug whic
- Intravenous nutrients for preventing inadvertent perioperative hypothermia in adults
Cochrane Systematic Reviews, 22-Nov-2016
Inadvertent perioperative hypothermia (a drop in core temperature to below 36°C) occurs because normal temperature regulation is disrupted during surgery, mainly because of the effects of anaesthetic drugs and exposure of the skin for prolonged periods. M
- Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease
Cochrane Systematic Reviews, 7-Sep-2011
Lung disease in preterm infants is often complicated with lung edema.
- Intravenous or intramuscular parecoxib for acute postoperative pain in adults
Cochrane Systematic Reviews, 29-May-2019
Parecoxib was the first COX-2 available for parenteral administration, and may, given intravenously or intramuscularly, offer advantages over oral medication when patients have nausea and vomiting or are unable to swallow, such as in the immediate postope
- Intravenous oxytocin alone for cervical ripening and induction of labour
Cochrane Systematic Reviews, 7-Oct-2009
Oxytocin is the commonest induction agent used worldwide. It has been used alone, in combination with amniotomy or following cervical ripening with other pharmacological or non-pharmacological methods.
- Intravenous prostaglandin for induction of labour
Cochrane Systematic Reviews, 23-Oct-2000
Intravenous prostaglandin E2 and F2 alpha can be used to induce labour, however their use is limited by unacceptable maternal side-effect profiles. This is one of a series of reviews of methods of cervical ripening and labour induction using standardised
- Intravenous secretin for autism spectrum disorders (ASD)
Cochrane Systematic Reviews, 18-Apr-2012
In 1998 secretin, a gastrointestinal hormone, was suggested as an effective treatment for autism spectrum disorders (ASD) based on anecdotal evidence.
- Intravenous thrombolytic treatment and endovascular thrombectomy for ischaemic wake‐up stroke
Cochrane Systematic Reviews, 1-Dec-2021
About one in five strokes occur during sleep (wake-up stroke). People with wake-up strokes have previously been considered to be ineligible for thrombolytic treatment because the time of stroke onset is unknown. However, recent studies suggest benefit fro
